190 related articles for article (PubMed ID: 27510203)
1. Beyond CRISPR: A guide to the many other ways to edit a genome.
Ledford H
Nature; 2016 Aug; 536(7615):136-7. PubMed ID: 27510203
[No Abstract] [Full Text] [Related]
2. Mini enzyme moves gene editing closer to the clinic.
Ledford H
Nature; 2015 Apr; 520(7545):18. PubMed ID: 25832387
[No Abstract] [Full Text] [Related]
3. CRISPR: gene editing is just the beginning.
Ledford H
Nature; 2016 Mar; 531(7593):156-9. PubMed ID: 26961639
[No Abstract] [Full Text] [Related]
4. Bacteria yield new gene cutter.
Ledford H
Nature; 2015 Oct; 526(7571):17. PubMed ID: 26432219
[No Abstract] [Full Text] [Related]
5. In vivo genome editing using Staphylococcus aureus Cas9.
Ran FA; Cong L; Yan WX; Scott DA; Gootenberg JS; Kriz AJ; Zetsche B; Shalem O; Wu X; Makarova KS; Koonin EV; Sharp PA; Zhang F
Nature; 2015 Apr; 520(7546):186-91. PubMed ID: 25830891
[TBL] [Abstract][Full Text] [Related]
6. Precise Genome Editing of Drosophila with CRISPR RNA-Guided Cas9.
Gratz SJ; Harrison MM; Wildonger J; O'Connor-Giles KM
Methods Mol Biol; 2015; 1311():335-48. PubMed ID: 25981484
[TBL] [Abstract][Full Text] [Related]
7. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
Pellagatti A; Dolatshad H; Valletta S; Boultwood J
Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
[TBL] [Abstract][Full Text] [Related]
8. Research: Biology's big hit.
Corbyn Z
Nature; 2015 Dec; 528(7580):S4-5. PubMed ID: 26630597
[No Abstract] [Full Text] [Related]
9. The CRISPR Way to Think about Duchenne's.
Calos MP
N Engl J Med; 2016 Apr; 374(17):1684-6. PubMed ID: 27119241
[No Abstract] [Full Text] [Related]
10. Methods in Enzymology. The use of CRISPR/Cas9, ZFNs, and TALENs in generating site-specific genome alterations. Preface.
Doudna JA; Sontheimer EJ
Methods Enzymol; 2014; 546():xix-xx. PubMed ID: 25398356
[No Abstract] [Full Text] [Related]
11. Replications, ridicule and a recluse: the controversy over NgAgo gene-editing intensifies.
Cyranoski D
Nature; 2016 Aug; 536(7615):136-7. PubMed ID: 27510204
[No Abstract] [Full Text] [Related]
12. Determining the specificities of TALENs, Cas9, and other genome-editing enzymes.
Pattanayak V; Guilinger JP; Liu DR
Methods Enzymol; 2014; 546():47-78. PubMed ID: 25398335
[TBL] [Abstract][Full Text] [Related]
13. Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
Kleinstiver BP; Prew MS; Tsai SQ; Topkar VV; Nguyen NT; Zheng Z; Gonzales AP; Li Z; Peterson RT; Yeh JR; Aryee MJ; Joung JK
Nature; 2015 Jul; 523(7561):481-5. PubMed ID: 26098369
[TBL] [Abstract][Full Text] [Related]
14. Recent Progress in CRISPR/Cas9 Technology.
Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
[TBL] [Abstract][Full Text] [Related]
15. Genome engineering using CRISPR-Cas9 system.
Cong L; Zhang F
Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
[TBL] [Abstract][Full Text] [Related]
16. A New Kid on the Playground of CRISPR DMD Therapy.
Duan D
Hum Gene Ther Clin Dev; 2017 Jun; 28(2):62-64. PubMed ID: 28609189
[No Abstract] [Full Text] [Related]
17. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
Jo YI; Suresh B; Kim H; Ramakrishna S
Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
[TBL] [Abstract][Full Text] [Related]
18. RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes.
Humphrey SE; Kasinski AL
J Hematol Oncol; 2015 Apr; 8():31. PubMed ID: 25888285
[TBL] [Abstract][Full Text] [Related]
19. CRISPR: taking the shortcut to a healthy genome editing enterprise.
Papadaki M
Regen Med; 2016 Apr; 11(3):229-34. PubMed ID: 26965833
[No Abstract] [Full Text] [Related]
20. Making the cut.
Travis J
Science; 2015 Dec; 350(6267):1456-7. PubMed ID: 26680172
[No Abstract] [Full Text] [Related]
[Next] [New Search]
